Article
“ <i>IL1B</i> loss is associated with increased AR activity in castration-resistant prostate cancer”
2021-09-01
Abstract excerpt
Castration-resistant prostate cancer represents a continuum of phenotypes, including tumors with high levels of androgen receptor (AR) expression and activity and those which do not express AR and rely on alternative pathways for survival. The process by which AR-positive prostate cancer cells and tumors lose AR expression and acquire neuroendocrine features is referred to as neuroendocrine differentiation. Numero...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 43af962b-18d3-55ba-909c-a7072e8869ba
- DOI
- 10.1101/2021.08.31.458406
